Another study linked the use of DPP-4 inhibitors to an increased rate of heart failure by showing that DPP-4 inhibitors activate the renin-angiotensin-aldosterone system (RAAS), which is involved in maintaining vascular tension and remodeling of the heart. Here, DPP4 is linked to heart failure.